Clostridium difficile infections in South East Scotland: Mortality and recurrence in a region without PCR ribotype 027

Journal of Medical Microbiology

Volumn 62, Issue , 2013, Pages 1468-1477

  Taori, Surabhi K ^a,b   Wroe, Allison ^a   Poxton, Ian R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; DEATH CERTIFICATE; DISEASE PREDISPOSITION; FEMALE; FOLLOW UP; HUMAN; INVASIVE PROCEDURE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MIXED INFECTION; MORTALITY; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENCE RISK; RECURRENT INFECTION; RIBOTYPING; SCHOOL CHILD; UNITED KINGDOM; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COINFECTION; COMORBIDITY; FECES; FEMALE; GENE DELETION; GENES, BACTERIAL; HUMANS; LEUKOCYTE COUNT; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; RECURRENCE; RIBOTYPING; SCOTLAND; SERUM ALBUMIN; STAPHYLOCOCCAL INFECTIONS; YOUNG ADULT;

EID: 84881561423     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.061093-0     Document Type: Article

References (42)

1. Abou Chakra, C. N., Pepin, J. & Valiquette, L. (2012). Prediction tools for unfavourable outcomes in Clostridium difficile infection: a systematic review. PLoS ONE 7, e30258.
2. Alonso, C. D., Treadway, S. B., Hanna, D. B., Huff, C. A., Neofytos, D., Carroll, K. C. & Marr, K. A. (2012). Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 54, 1053-1063.
3. Andrews, C. N., Raboud, J., Kassen, B. O. & Enns, R. (2003). Clostridium difficile-associated diarrhea: predictors of severity in patients presenting to the emergency department. Can J Gastroenterol 17, 369-373.
4. Anonymous (2006). Deaths involving Clostridium difficile: England and Wales,1999-2004. Health Statistics Quarterly Summer (30), 56-60.
5. Arvand, M., Hauri, A. M., Zaiss, N. H., Witte, W. & Bettge-Weller, G. (2009). Clostridium difficile ribotypes 001, 017, and 027 are associated with lethal C. difficile infection in Hesse, Germany. Euro Surveill 14, 19403.
6. Baldan, R., Cavallerio, P., Tuscano, A., Parlato, C., Fossati, L., Moro, M., Serra, R. & Cirillo, D. M. (2010). First report of hypervirulent strains polymerase chain reaction ribotypes 027 and 078 causing severe Clostridium difficile infection in Italy. Clin Infect Dis 50, 126-127.
7. Barbut, F., Richard, A., Hamadi, K., Chomette, V., Burghoffer, B. & Petit, J. C. (2000). Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea. J Clin Microbiol 38, 2386-2388.
8. Bauer, M. P., Notermans, D. W., van Benthem, B. H., Brazier, J. S., Wilcox, M. H., Rupnik, M., Monnet, D. L., van Dissel, J. T., Kuijper, E. J. & ECDIS Study Group (2011). Clostridium difficile infection in Europe: a hospital-based survey. Lancet 377, 63-73.
9. Bloomfield, M. G., Sherwin, J. C. & Gkrania-Klotsas, E. (2012). Risk factors for mortality in Clostridium difficile infection in the general hospital population: a systematic review. J Hosp Infect 82, 1-12.
10. Brazier, J. S. (1993). Role of the laboratory in investigations of Clostridium difficile diarrhea. Clin Infect Dis 16 (Suppl 4), S228-S233.
11. Cadena, J., Thompson, G. R., III, Patterson, J. E., Nakashima, B., Owens, A., Echevarria, K. & Mortensen, E. M. (2010). Clinical predictors and risk factors for relapsing Clostridium difficile infection. Am J Med Sci 339, 350-355.
12. Carter, G. P., Douce, G. R., Govind, R., Howarth, P. M., Macin, K. E., Spencer, R. J., Buckley, A. M., Antunes, A., Kotsanas, D., Jenkin, G. A., Dupuy, B., Rood, J. I. & Lyras, D. (2011). The anti-sigma factor TcdC modulates hypervirulence in an epidemic BI/NAP1/027 clinical isolate of Clostridium difficile. PLoS Pathog 7, e1002317.
13. Chang, K., Kreuziger, L. M., Angell, K., Young, J. A. & Ustun, C. (2012). Recurrence of Clostridium difficile infection after total colectomy in an allogeneic stem cell transplant patient. Bone Marrow Transplant 47, 610-611.
14. Choi, H. K., Kim, K. H., Lee, S. H. & Lee, S. J. (2011). Risk factors for recurrence of Clostridium difficile infection: effect of vancomycinresistant enterococci colonization. J Korean Med Sci 26, 859-864.
15. Curry, S. R., Marsh, J. W., Muto, C. A., O'Leary, M. M., Pasculle, A. W. & Harrison, L. H. (2007). tcdC genotypes associated with severe TcdC truncation in an epidemic clone and other strains of Clostridium difficile. J Clin Microbiol 45, 215-221.
16. Das, R., Feuerstadt, P. & Brandt, L. J. (2010). Glucocorticoids are associated with increased risk of short-term mortality in hospitalized patients with Clostridium difficile-associated disease. Am J Gastroenterol 105, 2040-2049.
17. Dharmarajan, T., Sipalay, M., Shyamsundar, R., Norkus, E. & Pitchumoni, C. (2000). Co-morbidity, not age predicts adverse outcome in Clostridium difficile colitis. World J Gastroenterol 6, 198-201.
18. Eyre, D.W., Walker, A. S., Wyllie, D., Dingle, K. E., Griffiths, D., Finney, J., O'Connor, L., Vaughan, A., Crook, D. W. & other authors (2012). Predictors of first recurrence of Clostridium difficile infection: implications for initial management. Clin Infect Dis 55 (Suppl 2), S77-S87.
19. Fekety, R., McFarland, L. V., Surawicz, C. M., Greenberg, R. N., Elmer, G. W. & Mulligan, M. E. (1997). Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial. Clin Infect Dis 24, 324-333.
20. Goldenberg, S. D. & French, G. L. (2011). Lack of association of tcdC type and binary toxin status with disease severity and outcome in toxigenic Clostridium difficile. J Infect 62, 355-362.
21. Goorhuis, A., Debast, S. B., Dutilh, J. C., van Kinschot, C. M., Harmanus, C., Cannegieter, S. C., Hagen, E. C. & Kuijper, E. J. (2011). Type-specific risk factors and outcome in an outbreak with 2 different Clostridium difficile types simultaneously in 1 hospital. Clin Infect Dis 53, 860-869.
22. Gujja, D. & Friedenberg, F. K. (2009). Predictors of serious complications due to Clostridium difficile infection. Aliment Pharmacol Ther 29, 635-642.
23. Hall, W. H., Ramachandran, R., Narayan, S., Jani, A. B. & Vijayakumar, S. (2004). An electronic application for rapidly calculating Charlson comorbidity score. BMC Cancer 4, 94.
24. Hardt, C., Berns, T., Treder, W. & Dumoulin, F. L. (2008). Univariate and multivariate analysis of risk factors for severe Clostridium difficileassociated diarrhoea: importance of co-morbidity and serum Creactive protein. World J Gastroenterol 14, 4338-4341.
25. Hensgens, M. P., Goorhuis, A., Dekkers, O. M., van Benthem, B. H. & Kuijper, E. J. (2013). All-cause and disease-specific mortality in hospitalized patients with Clostridium difficile infection: a multicenter cohort study. Clin Infect Dis 56, 1108-1116.
26. HPA (2008). Clostridium Difficile Infection: How to Deal with the Problem. London: Department of Health.
27. Kamboj, M., Khosa, P., Kaltsas, A., Babady, N. E., Son, C. & Sepkowitz, K. A. (2011). Relapse versus reinfection: surveillance of Clostridium difficile infection. Clin Infect Dis 53, 1003-1006.
28. Knetsch, C. W., Hensgens, M. P., Harmanus, C., Van Der Bijl, M. W., Savelkoul, P. H., Kuijper, E. J., Corver, J. & Van Leeuwen, H. C. (2011). Genetic markers for Clostridium difficile lineages linked to hypervirulence. Microbiology 157, 3113-3123.
29. Labbé, A. C., Poirier, L., Maccannell, D., Louie, T., Savoie, M., Béliveau, C., Laverdière, M. & Pépin, J. (2008). Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain. Antimicrob Agents Chemother 52, 3180-3187.
30. McDonald, L. C., Coignard, B., Dubberke, E., Song, X., Horan, T., Kutty, P. K. & Ad Hoc Clostridium difficile Surveillance Working Group (2007). Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 28, 140-145.
31. Morrison, R. H., Hall, N. S., Said, M., Rice, T., Groff, H., Brodine, S. K., Slymen, D. & Lederman, E. R. (2011). Risk factors associated with complications and mortality in patients with Clostridium difficile infection. Clin Infect Dis 53, 1173-1178.
32. O'Neill, G. L., Ogunsola, F. T., Brazier, J. S. & Duerden, B. I. (1996). Modification of a PCR ribotyping method for application as a routine typing scheme for Clostridium difficile. Anaerobe 2, 205-209.
33. Pépin, J., Valiquette, L., Gagnon, S., Routhier, S. & Brazeau, I. (2007). Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027. Am J Gastroenterol 102, 2781-2788.
34. Persson, S., Jensen, J. N. & Olsen, K. E. (2011). Multiplex PCR method for detection of Clostridium difficile tcdA, tcdB, cdtA, and cdtB and internal in-frame deletion of tcdC. J Clin Microbiol 49, 4299-4300.
35. Reddy, S., Taori, S. & Poxton, I. R. (2010). Changes in laboratory and clinical workload for Clostridium difficile infection from 2003 to 2007 in hospitals in Edinburgh. Clin Microbiol Infect 16, 340-346.
36. Spencer, R. C. (1998). Clinical impact and associated costs of Clostridium difficile-associated disease. J Antimicrob Chemother 41 (Suppl 3), 5-12.
37. Stubbs, S. L., Brazier, J. S., O'Neill, G. L. & Duerden, B. I. (1999). PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J Clin Microbiol 37, 461-463.
38. Tal, S., Gurevich, A., Guller, V., Gurevich, I., Berger, D. & Levi, S. (2002). Risk factors for recurrence of Clostridium difficile-associated diarrhea in the elderly. Scand J Infect Dis 34, 594-597.
39. Verdoorn, B. P., Orenstein, R., Rosenblatt, J. E., Sloan, L. M., Schleck, C. D., Harmsen, W. S., Nyre, L. M. & Patel, R. (2010). High prevalence of tcdC deletion-carrying Clostridium difficile and lack of association with disease severity. Diagn Microbiol Infect Dis 66, 24-28.
40. Walk, S. T., Micic, D., Jain, R., Lo, E. S., Trivedi, I., Liu, E. W., Almassalha, L. M., Ewing, S. A., Ring, C. & other authors (2012). Clostridium difficile ribotype does not predict severe infection. Clin Infect Dis 55, 1661-1668.
41. Wilcox, M. H., Fawley, W. N., Settle, C. D. & Davidson, A. (1998). Recurrence of symptoms in Clostridium difficile infection-relapse or reinfection? J Hosp Infect 38, 93-100.
42. Wilson, V., Cheek, L., Satta, G., Walker-Bone, K., Cubbon, M., Citron, D., Gerding, D. N. & Llewelyn, M. J. (2010). Predictors of death after Clostridium difficile infection: a report on 128 strain-typed cases from a teaching hospital in the United Kingdom. Clin Infect Dis 50, e77-e81.